Mycological Society of America

Total Page:16

File Type:pdf, Size:1020Kb

Mycological Society of America MYCOLOGICAL SOCIETY OF AMERICA NEWS - LETTER JUNE 1960 VOL. XI NO. I I\iYCOLOGICAL SOCIETY OF AMERICA NEWSLETTER - JUNE, 1963 VOL. XI NO. 1 Edited by: R. K. Benjamin CONTENTS Presidential Remarks- The Annual Meet ing-1960, Oklahoma State University. The Annual Foray-1960, Baton Rouge, Louisiana. Mycological Society Fellowship. Election of Officers. Brochure-"A Career in Mycology." VII. VIII. Sustaining Members. Publicat ions. Research Materials Major Research Projects. XII. Mycological Instruct ion, Summer of 1960, and Ne~w Courses. XIII. Vacancies for Mycologically Trained Personnel. XIV. Assistantships, Fello~~~ships,and Scholarships. Mycologists Available. XVI Recent Appointments and Transfers. XVII. News of General Interest. XVIII* Other News about Members. XIX Visiting Scientists. Honors, Degrees, Promotions, Invitational Lectures. XXI The F1 - F2 Generations. Mycological Poetry. I. President's greetings to the Mycological Society of America. I take this opportunity, my first to address members of the Mycol- gical Society officially, to thank you for the honor of my election as -,our president. It is the highest and most coveted honor I can expect to receive, but it is more than a personal honor. I interpret it as a recognition of the importance of an applied branch of mycology, im~ort- ant in medicine and public health. Thirty years of my professional career have been spent in the fas- cinating specialty of medical mycology, but throughout that time one of my primary goals has been that medical mycology shall be a specialty of mycology and not a special branch of either clinical medicine or med- ical bacteriology, to both of which it is closely allied. During these 30 years, I have seen competent mycologists take increasing responsib- ilities for medical mycology and now, despite the acknowledged hazards of including medical mycology within the scope of general laboratory mycology, the subject is well taught at an academic level in many myco- logical centers. I have fostered this ideal personally by maintaining a deep personal interest in morphologic and cytologic mycology and some of my research studies in which I take most satisfaction have had no direct relationship to fungi of medical importance. The Mycological Society should not now expect to recover dominance in the fields of antibiotics, plant pathology, and biochemical studies which utilize fungi merely as tools, but it must broaden the scope of its interest and its journal to encompass these specialities as well as descriptive and taxonomic mycology. Progress has been made in this dir- ection during the past 10 years and it has strengthened and improved the Society. Mycology, in its many ramifications, is a most fa-acinating field of microbiology, with potentialities as the most productive didact- ically, industrially, and even medically (despite the fact that fungi are reported as the cause of death in only 350-450 cases in the United States each gear). Our new Secretary-Treasurer has done a fine job of taking over the responsibilities of this important office. I thank him and those mem- bers who ha-ve accepted appointments on committees. Responsible act- ivity in these appointments and in elective offices are essential to a vigorous development of our Society. Growth in membership is important too and, although expansion in size is limited by necessity, growth in responsibility and active participation is a desirable and adequate sub- stitute. We have an interesting program planned for the fall foray and the annual meeting at S$illv~ater,Oklahoma. Further announcements about these will reach you in due course. I hope you can all attend these meetings and I look forward with pleasure to seeing you there. Chester W. Emmons 11. THE ANNUAL MEETING--~~~o,OKLAHOlqA STATE UNIVERSITY August 28 - September 1, 1960 Information on housing accommodations and food service has been pub- lished in the April issue of the AIBS Bulletin, pp. 34-35. In general, the procedure at Stillwater ?firill be similar to that of AIBS meetings held in the past. An application form is included in this issue of the Newsletter (p.23) for the convenience of members needing one. Dr. Chester W. Emmons will deliver the presidential address, and the eleventh annual lecture will be presented by a distinguished mycologist being selected by the eminently well-qualified committee consisting of Drs. John Couch, Chm., Leland Shanor, and John Stevenson. A symposium on "Some Biotic Relationships of Algaell--dedicated to the memory of Prof. Gilbert Ma Smith--?rill be sponsored jointly by the Microbiological and Phycological Sections of the Botanical Society and the Mycological and Phycological Societies. Local arrangements for the Mycological Society are in the hands of Dr. John E. Thomas, Department of Botany and Plant Pathology, Oklahoma State University. 111- TEE ANNUAL FORAY - BATON ROUGE, LA* August 23-25, 1960 The follooring information will be of interest to those members ~erho are planning to attend the 1960 Foray to be held at Louisiana State University-, Baton Rouge, on August 23-25 preceeding the Stillwater meetings. The Department of Botany, Bacteriology and Plant Pathology ill pro- vide participants with all necessary laboratory equipment and the facili- ties of the library and mycological herbarium will be at their disposal. Two "all dayu collecting trips are planned, one to a hardwood area about 65 miles north of the campus, to include a stop at Audubon Memorial State Park; another will be to the pinewood area about 60 miles east of Baton Rouge. The third day of collecting vill be in localities closer to the campus and >$illend about noon leaving the afternoon of the 25th free. Collecting at this time of year usually is very good and we cordially in- vite your participation. Transportation to the collecting areas ?rill be by car. Louise Garig Hall, a women's dormitory, has been reserved for the housing of members. The cost will be $2.75 per person per night with maid service and linens furnished daily. Meals will be served at a restaurant located at the entrance to the campus about 500 yards from the dormitory area. Rooms will be ready for occupancy on the morning of August 22 a.nd registrants may check in at any time throughout the day. Upon receipt of your advance registration form (see p. 25), a campus map will be mailed to you appropriately marked for your orientation. Upon arrival, please go directly to Louise Garig Hall. If you plan to arrive in Baton Rouge by means of transportation other than by car please write in advance and ar- rangemento will be made to meet you at bus, train or plane terminal. For those members who plan to drive to Stillwater after the Foray (leaving Louisiand State University on the morning of August 26), ar- rangements will be made to supply them with marked Esso roadmaps for the trip from Baton Rouge. Also, for those members who so desire, ad- vance registration at a motel (Holiday Inn) in Texarkana, Texas (about -2- midwey between Baton Rouge and stillwater) will be made if they indicate the type of accommodation desired (see registration form). Please indicate your wishes on the form and return promptly to : B. Lowy, Botany Depart- ment, Louisiana State University, Baton Rouge, Louisiana. All inquiries should be addressed to Dr. Lowy. Members of the Foray Committee on local arrangements are: Drs. B. Lowy, Cha-irman, S. J.P. Chilton, B. Exner, and H. Wheeler. IV. MYCOLOGICAL SOCIETY FELLOWSHIP The Research Grants Committee of the Mycological Society of America takes pleasure in announcing that it has selected Mr. Francis A. Wood, Department of Botany and Plant Pathology, University of Minnesota, as the recipient of the Mycological Society Graduate Fellowship for 1960-1961. The committee consists of Drs. Harry E. Wheeler, Chairman, Alma W. Barks- dale, Kenneth B. Raper, and John E. Peterson (EX-~fficio). V* ELECTION OF OFFICERS I\lominations have been received for the four officers to be elected in 1960, and the ballots trill be mailed as soon as possible after those persons selected by the membership have accepted nomination. VI. BROCHURE "A CAREER IN MYCOLOGY'' Since announcing the availability of the Society's brochure--"A Car- eer in Mycology1'--in the last issue of the Newsletter, over 1600 copies have been distributed. Many of these have gone to state and local Dep- artments of Education, High Schools, etc., for the use of counselors and students. Your editor still has some 3400 brochures on hand. These re- present a considerable investment of nioney by the Society and they serve no useful purpose in storage. Please send requests to R. K. Benjamin, Rancho Santa Ana Botanic Garden, Claremont, California. VII. 3JEMBERSHIP As of May 25, 1960, the membership of the Society including applications on hand to be presented for election at the annual business meeting in Aug- ust was constituted as follows: Life Members ........................................ 7 Regular Members ....................................... 717 Associate Members ..................................... 24 Emeritus Members ...................................... 10 Corresponding Members ................................. 3 Sustaining Members .................................... 22 Affiliated Societies .................................. 5 With 788 members in all categories, the Society shows a gain of 19 members over last year, and, notwithstanding delay in the publication of -Pi>-cologia, only 53 regular members have not yet paid their 1960 dues. This compares ~lrith56 unpaid members this time last year. Happily, none of our members has died since publication of the last issue of the Nevrs- letter; fourteen regular members have resigned. Application Forms A new supply of application-for-membership forms is on hand. These may be obtained by writing any member of the Membership Committee (see page 6 of previous issue of Newsletter) or the Secretary-Treasurer. -New Sustaining Members Five new Sustaining Members have joined the Society since the last Newsletter was published. These are: Burroughs Wellcome and Co.
Recommended publications
  • Cholesterol How Kos Beat Big Pharma to HDL
    The Other Cholesterol How Kos Beat Big Pharma to HDL www.pharmexec.com | ANADVANSTAR★ PUBLICATION Kos CEO Adrian Adams PHARMACEUTICAL EXECUTIVE Contents OCTOBER 2004 www.pharmexec.com Cover Story Under Construction Patrick Clinton Editor-in-Chief How Kos Pharmaceuticals turned a 50-year-old drug for raising HDL cholesterol into a brand-new, burgeoning business. Mulling the Future Kos CEO Adrian Adams, seated, maps strategy with key executives: (from left) Ralf Rosskamp, Christopher Kiritsy, Richard King, and Mark McGovern “We didn’t start with the idea of being a $200 million company. Growing as fast as possible: That was our goal from the get-go.” Kos Pharmaceuticals was first to market with a product to raise HDL cholesterol, and it wants to join pharma’s billion-dollar club by 2007. Big plan. Under Here’s how it’s going. Construction t’s hard to imagine that many pharma companies experienced more plain old good news this summer than Kos Pharmaceuticals. First, there were the second-quarter financials. Revenues for the quarter were $120.3 million, almost double last year’s figure. Net income for the quarter grew 245 percent to $38.5 million. The company raised its guidance for the year, predicting that full-year sales would be $480 million, 60 percent over last year— and CEO Adrian Adams boasted that Kos was the fastest-growing specialty pharma company in the United States. A few weeks later came encouraging results from a Phase II trial of IKos’ new inhalable insulin product for diabetes, and recruitment began for pivotal trials of a new combination product to consolidate Kos’ position in the burgeoning cholesterol market.
    [Show full text]
  • Board of Director Candidates
    2021 Annual General Meeting Board of Director Candidates James I. Healy, M.D., Ph.D. (Current Board Member) James I. Healy, M.D., Ph.D. has served as a member of our board of directors since November 2014. Dr. Healy has been a General Partner of Sofinnova Investments, Inc. (formerly Sofinnova Ventures), a venture capital firm, since June 2000. Prior to June 2000, Dr. Healy held various positions at Sanderling Ventures, Bayer Healthcare Pharmaceuticals (as successor to Miles Laboratories) and ISTA Pharmaceuticals, Inc. Dr. Healy is currently on the board of directors of Bolt Therapeutics, Inc. (Nasdaq: BOLT), Coherus BioSciences, Inc. (Nasdaq: CHRS), Karuna Therapeutics, Inc. (Nasdaq: KRTX), Natera, Inc. (Nasdaq: NTRA), NuCana plc (Nasdaq: NCNA), ObsEva SA (Nasdaq: OBSV) and Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) and two private companies. Previously, he served as a board member of Amarin Corporation, Auris Medical Holding AG, Edge Therapeutics, Inc., Hyperion Therapeutics, Inc., InterMune, Inc., Iterum Therapeutics PLC, Anthera Pharmaceuticals, Inc., Durata Therapeutics, Inc., CoTherix, Inc., Movetis NV and several private companies. Dr. Healy holds an M.D. and a Ph.D. in Immunology from Stanford University School of Medicine and holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from the University of California, Berkeley. Jan Møller Mikkelsen (Current Board Member) Jan Møller Mikkelsen founded Ascendis Pharma and has served as President and Chief Executive Officer as well as Board member since December 2007 and currently serves on the board of Visen. From 2002 to 2006, Mr. Mikkelsen served as President and Chief Executive Officer of LifeCycle Pharma A/S, now Veloxis Pharmaceuticals A/S, which was a publicly traded biotechnology company.
    [Show full text]
  • Medication Precautions
    MEDICATION PRECAUTIONS If you want to be pro-active to decrease bruising during injection treatments such as Restylane, Botox and Mesotherapy; the following prescriptions and non-prescription medications may be discontinued for at least two weeks prior to having any injection procedure to ensure that your platelets have time to recover. These specific preparations have been found to affect your blood by decreasing the amount of time it takes for coagulation and decreasing the amount of red blood cell production which can lead to increased bruising. If you are taking any antiarthritics or anticoagulants for control of a medical disorder, you will need to consult your treating physician for recommendations as to the alternatives. If you must take these medications, appropriate determinations as to whether they may be a detriment during the procedure may be discussed. NONPRESCRIPTION MEDICATIONS • Aspirin combinations • Alka-Seltzer Effervescent Antacid & Pain Reliever (Miles Laboratories) • Alka-Seltzer (Flavored) Effervescent Antacid & Pain Reliever (Miles Laboratories) • Alka-Seltzer Extra Strength Effervescent Antacid & Pain Reliever (Miles Laboratories) • Anacin Analgesic Coated Caplets (Whitehall) • Anacin Analgesic Coated Tablets (Whitehall) • Anacin Maximum Strength Coated Analgesic Tablets (Whitehall) • Arthritis Pain Formula by the Makers of Anacin Analgesic Tablets and Caplets (Whitehall) • Arthritis Strength BC Powder (Block) • Ascriptin Tablets (Rorer) • Ascriptin A/D Tablets (Rorer) • Bayer Children’s Chewable Aspirin (Glenbrook)
    [Show full text]
  • Editorial Board L
    EDITORIAL BOARD L. LEON CAMPBELL, Editor-in-Chief University ofIllinois, Urbana L. S. BARON, Editor (1969) L. JOE BERRY, Editor (1968) Ifalter Reed Army Institute ofResearch, Washington, D.C. Bryn Mawr College, Bryn Mawr, Pa. R. D. DeMOSS, Editor (1970) University ofIllinois, Urbana R. L. Anderson (1969) Herman Friedman (1969) Robert C. Parlett (1969) Robert Austian (1969) Lorraine Friedman (1968) Harry D. Peck (1970) W. Lane Barksdale (1969) Ruth E. Gordon (1969) Michael J. Pelczar, Jr. (1969) S. S. Barkulis (1969) Joseph S. Gots (1969) H. J. Phaff (1969) Alan W. Berheimer (1969) Leonard Hayflick (1969) Roy Repaske (1969) Robert W. Bernlohr (1970) James G. Hirsch (1969) H. V. Rickenberg (1970) S. Gaylen Bradley (1969) John G. Holt (1969) C. F. Robinow (1969) Arnold F. Brodie (1970) Paul Howard-Flanders (1969) W. R. Romig (1969) Allan Campbell (1969) Jerard Hurwitz (1969) NM R. J. Salton (1969) George B. Chapman (1969) Arthur G. Johnson (1969) Russell W. Schaedler (1969) V. P. Cirillo (1970) Elliot Juni (1967) W. R. Sistrom (1969) A. J. Clark (1969) R. E. Kallio (1969) Louis DS. Smith (1968) V. W. Cochrane (1969) Carl Lamanna (1970) Paul F. Smith (1970) S. F. Conti (1969) Maurice Landy (1970) Roger Y. Stanier (1970) C. D. Cox (1969) H. S. Levinson (1969) M. P. Starr (1970) William J. Cromartie (1969) H. C. Lichstein (1970) B. A. D. Stocker (1969) Roy Curtiss m (1969) W. R. Lockhart (1969) Bernard S. Strauss (1969) A. L. Demain (1969) Donald G. Lundgren (1968) Curtis B. Thorne (1969) Eliznbe McCoy (1969) John A. DeMoss (1969) H.
    [Show full text]
  • Biogen Idec Inc. (Exact Name of Registrant As Specified in Its Charter)
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-19311 Biogen Idec Inc. (Exact name of registrant as specified in its charter) Delaware 33-0112644 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 14 Cambridge Center, Cambridge, Massachusetts 02142 (Address of principal executive offices) (Zip code) (617) 679-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.0005 par value Series X Junior Participating Preferred Stock Purchase Rights (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • Alternatives to Animal Use in Research, Testing, and Education
    Appendix Laboratory-Animal Facilities Fully Accredited by the American Association for Accreditation of Laboratory Animal Care As of April 1, 1985, there were 483 facilities listed Michigan: as fully accredited by the American Association for University of Michigan, Ann Arbor, Dearborn, Accreditation of Laboratory Animal Care (AAALAC) and Flint (New Lenox, IL). Institutions are categorized as univer- Wayne State University, Detroit sities, medical schools, combined facilities for health Missouri: sciences, veterinary schools, dental schools, colleges University of Missouri-Kansas City, Kansas City of pharmacy, colleges of biological science, colleges of Montana: arts, colleges of engineering, Veterans’ Administration University of Montana, Missoula medical centers, pharmaceutical manufacturers, gov- Nebraska: ernment laboratories, commercial laboratories, hos- University of Nebraska at Omaha, Omaha pitals, nonprofit research laboratories, or laboratory New York: animal breeders. The following list of AAALAC-accred- St. John’s University, Jamaica ited facilities numbers 538, as some institutions are State University of New York at Buffalo, Buffalo listed in more than one category. (Facilities receiving Rockefeller University, New York accreditation since April 1, 1985, are not listed.) North Carolina: Duke University, Durham Oklahoma: Universities Oral Roberts University, Tulsa (Programs serving an entire campus) Rhode Island: Brown University, Providence Alabama: South Carolina: University of Alabama, University University of South Carolina,
    [Show full text]
  • Robert J. Desalvo Papers Business Combinations in the Cosmetic and Pharmaceutical Industries 1944
    Robert J. DeSalvo Papers Business Combinations in the Cosmetic and Pharmaceutical Industries 1944 - 1990 Collection #107 Abstract Robert J. DeSalvo’s research focused on business combinations (acquisitions, mergers, and joint ventures in the cosmetic and pharmaceutical industries. This topic was the basis for his master’s thesis in pharmacy administration at the University of Pittsburgh and continued as a life-long interest. This collection consists of two series of notebooks that Dr. DeSalvo developed to record relevant business combinations. The first series records acquisitions, proposed acquisitions, mergers, and joint ventures for the period of 1944 –1990 in an alphabetical arrangement. The information on these entries is cumulative so that the history of an organization is collected in one place. The second series of notebooks is arranged in chronological blocks. The information is arranged alphabetically by the name of the acquirer. The name of the acquired (merged), type of combination (acquisition, proposed acquisition, joint venture) and the date is also provided. The information is cross-referenced between the two series so that the researcher can approach the information by the name of the parent company or chronologically. Dr. DeSalvo used this resource for many of his publications as well as his master’s thesis. A copy of these publications and his thesis make up the remainder of the collection. Donor Gift of Barbara DeSalvo, 2000 Biography Robert James DeSalvo was born on July 20, 1933 in Toledo, OH. He died on January 23, 1993 in Cincinnati, OH. DeSalvo graduated from high school in Toledo and attended pharmacy school at the University of Toledo where he received his B.S.
    [Show full text]
  • Board of Director Candidates
    2017 Annual General Meeting Board of Director Candidates James I. Healy, M.D., Ph.D. (Current Board Member) James I. Healy, M.D., Ph.D. has served as a member of our board of directors since November 2014. Dr. Healy has been a General Partner of Sofinnova Ventures, a venture capital firm, since June 2000. Prior to June 2000, Dr. Healy held various positions at Sanderling Ventures, Bayer Healthcare Pharmaceuticals (as successor to Miles Laboratories) and ISTA Pharmaceuticals, Inc. Dr. Healy is currently on the board of directors of Auris Medical Holding AG, Coherus BioSciences, Inc., Edge Therapeutics, Inc., natera, Inc., ObsEva SA and several private companies. Previously, he served as a board member of Amarin Corporation, Hyperion Therapeutics, Inc., InterMune, Inc., Anthera Pharmaceuticals, Inc., Durata Therapeutics, Inc., CoTherix, Inc., Movetis NV and several private companies. Dr. Healy is currently a Director on the Board of the National Venture Capital Association (NVCA) and the Board of the Biotechnology Industry Organization (BIO). In 2011, Dr. Healy won the IBF Risk Innovator Award and was named as one of the industry’s top leading Life Science investors in 2013 by Forbes Magazine. Dr. Healy holds an M.D. and a Ph.D. in Immunology from Stanford University School of Medicine and holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from the University of California, Berkeley. Jan Møller Mikkelsen (Current Board Member) Jan Møller Mikkelsen founded Ascendis Pharma and has served as our President and Chief Executive Officer and as a member of our board of directors since December 2007.
    [Show full text]
  • American Foundation for Pharmaceutical Education Box: 8
    Ronald Reagan Presidential Library Digital Library Collections This is a PDF of a folder from our textual collections. Collection: Turner, Carlton E.: Files Folder Title: American Foundation for Pharmaceutical Education Box: 8 To see more digitized collections visit: https://reaganlibrary.gov/archives/digital-library To see all Ronald Reagan Presidential Library inventories visit: https://reaganlibrary.gov/document-collection Contact a reference archivist at: [email protected] Citation Guidelines: https://reaganlibrary.gov/citing National Archives Catalogue: https://catalog.archives.gov/ .. i ! f;c~~~ I I ,J I American Foundation For Pharmaceutical Education I OIRECTOF)S RADBURN PLAZA BUILDING 14-25 PLAZA ROAD, FAIR LAWN, N.J. 07410 Ronald J. Brenner. Ph.D. (201) 791-5192 INCORPORATED 1942 Cytogen Corpnr~lion William H. Campbell. Ph .D. March 3, 1986 Unfrersity of Washington Herbert 5. Carlin OFFICERS The New York Hospital Peter G. Tombros. Chaimratt of Board Paul N. Clark Abbott Wboralories Ronald J. Brenner. Ph.D .. Via Clwimum of Board L. Jack R. Cole. Ph.D. Robert Hanson, Treasurer William F. Weigel. Coumel and S(•aetary Uni\·ersity of Ariwna Thomas M. Collins Carlton E. Turner, Ph.D. E. PresitJ,,,u SmithK/i11e Beckman Corpora/ion Richard Faust. Ph.D .. Herbert J. Conrad Deputy Assistant to the President Hoffmann-Lo Roche Inc. for Drug Abuse Policy John W. Culligan American Home Products Corporation The White House Angele C. D"Angelo Washington, DC 20001 St. John's University Robert A . Dube Owens-Illinois Dear Carlton, Frederick M. Eckel 1he University of Nonh Carolina George W. Eckelmann Thanks for your kind note just before the holidays ..
    [Show full text]
  • Directory of North Carolina Manufacturing Firms
    7 PRODUCT GUIDE SIC 2824-2841 SYNTHON TEXTILE INC SCHERER. R P CORP S E GOODYS MFG CORP (WELLCOME FOUNDATION LTD INC 26 Glendale Avenue Biltmore P Box 847 P Box 10518 Salem Station Burroughs Wellcome Co IE Asheville 28803 Monroe 281 10 Winston Salem 27108 PO Box 1887 Buncombe County Emp. C Union County Emp. F Forsyth County Emp. E Greenville 27834 " Phone: (704)253-8453 Phone: (704)289-5451 Phone: (919)723-1831 Pitt County Emp I Polyester fibers Nutritional supplements Headache powders Phone: (919)758-3436 Drugs Veterinary products GREER LABORATORIES INC E WHITAKER. FRED I CO Drugs & chemicals (packaged) P Box 27506 STANBACK CO P Box 800 Lenoir 28645 Raleigh 27611 Box 1669 2841 SOAP AND OTHER DETERGENTS Salisbury 28144 Caldwell County Emp. F Wake County Emp E EXCEPT SPECIALTY CLEANERS Phone: (919)832-8383 Rowan County Emp. E Phone: (704)754-5327 Synthetic fibers Phone: (704)633-9231 Allergenic extract ACME SOUTHERN INC Breath freshner HORNE HEALTH CARE P Box 1 1264 2831 BIOLOGICAL PRODUCTS Chap et lip balm P Box 206 Charlotte 28220 Headache powders Everetts 2 7825 Mecklenburg County Emp. D AMERICAN LABORATORY SUPPLY INC Martin County Emp D Phone: (704)523-1452 P Box 1096 WINTON PRODUCTS CO INC E Phone: (919)792-4135 Various textile specialties Burlington 27215 P Box 36332 Cough syrups & antihistamines Alamance County Emp C Charlotte 28236 ADVANCED CHEMICAL TECHNOLOGY INC Phone: (919)229-5865 Mecklenburg County Emp. B tMALLINCKRODT INC 2151 Hawkins St Prepared microbiological cultures Phone: (704)399-5151 Parenteral Plant IE Charlotte 28203 Rodent repellent PO Box 61038 Mecklenburg County Emp.
    [Show full text]
  • Recovery of Fermentation Products Engineering Foundation Conference Co-Chairs Charles L
    Recovery of Fermentation Products Engineering Foundation Conference Co-chairs Charles L. Cooney, Massachusetts Institute of Technology, USA Kenneth G. Taksen, Pfizer, Inc., USA The Cloister, Sea Island, Georgia, USA 29 January - 3 February, 1984 Sunday, 29 January Tuesday, 31 January Plenary Lectures Purification Methods: Chromatography and Separations Technology: Achilles Heel of the Adsorption Bioprocess Industries Session Chairs E. Gaden, University of Virginia, USA Saxena, Bio Rad Laboratories, USA Innovation in Separations: Key to Success in M. Ladisch, Purdue University, USA Adapting Modern Biology to Industrial Practice Scale-Up Considerations in Process HPLC A. Michaels, USA V Saxena, BioRad Laboratories, USA Purification of Pharmaceutical Compounds by Monday, 30 January Process HPLC W. Skea, Millipore Corp., USA Cell Disruption and Harvesting Scale-up of Affinity Chromatography Session Chairs H. W. Blanch, University of California, USA J. Sinskey, Massachusetts Institute of Technology, USA Protein Recovery from Unclarified Cell Homogenates C.G. Rosen, Alfa Laval, Sweden P. Hedman, Pharmacia Fine Chemicals, Sweden Centrifugal Separation in Biotechnology Selective Recovery of Polar Organics by Solvent A. Larsson, Alfa Laval Separation, Sweden Regenerated Adsorptive Processes Genetic Solutions to Cell Disruption Problems C. J. King, University of California, USA A. J. Sinskey, Massachusetts Institute of Technology, Column Design Factors in Aqueous Liquid USA Chromatography of Fermentation Substrates and Production and Reaction Kinetics of Microbial Cell- Products Lytic Enzyme Systems M. R. Ladisch, Purdue University, USA J. Asenjo, B. A. Andrews and J. B. Hunter, Columbia University, USA Purification Methods: Extraction Mechanical Disruption of Cells Session chair C. Engler, Texas A & M University, USA J. King, University of California, USA Strategy, Tactics and Constraints in Applying Liquid- Purification Methods: Membrane Process Liquid Extraction to the Biotechnology Field Session chair R.
    [Show full text]
  • Europe's Pharmaceutical Industry an Innovation
    EUROPEAN INNOVATION MONITORING SYSTEM (ElMS) ElMS PUBLICATION N° 32 EUROPE'S PHARMACEUTICAL INDUSTRY AN INNOVATION PROFILE BY SPRU, U Diversity of Sussex, UK EUROPEAN COMMISSION DIRECTORATE GENERAL XIII - The Innovation Programme -)( U,j uJ (..) ElMS Project N° 94/114 ... .. ! w THIS STUDY WAS COMMISSIONED BY THE I EUROPEAN COMMISSION, I DIRECTORATE-GENERAL "TELECOMMUNICATIONS, INFORMATION MARKET AND ExPLOITATION OF RESEARCH", UNDER THE INNOVATION PROGRAMME STUDY FINISHED ON: AUGUST96 © 1996, European Commission {'15 b: Ytir/17 I ., Ii • !' .. Contents Page 1 Introduction 1 2 Current Developments in the Pharmaceutical Industry 2 3 Major Market and Technology Trends 12 4 Firm Level Analysis 24 5 Biotechnology - A New Route to Drug Discovery 40 6 Alliances, Linkages and Technology Transfer 49 7 Conclusions 56 REFERENCES 61 Tables: 1: Trends in R&D Intensity of the Pharmaceuticals Sector 4 2: Major Take-overs 1990-1996 8 3: Top Twelve World Market Share with Newly Merged Companies 9 4: Health Expenditure and Pharmaceutical Consumption in Developed Countries 13 5: Pharmaceutical Production in Major World Markets 15 6: R&D Intensity by Industry 18 7: Trends in the Distribution of Pharmaceutical R&D 19 8: Trends in the Distribution of US Patenting in Pharmaceuticals 21 9: Top 50 Branded Products by Country of Origin 23 10: Company Rankings by sales 1993 26 11: Changing Places -the world's top 20 pharmaceutical corporations 1976-94 27 12: Seller Concentration Ratios in the Pharmaceutical Industry 30 13: Top 20 companies in terms of Pharmaceutical R&D expenditures 31 14: Company market share in Europe, United States and Japan 34 15: Geographic Location of Pharmaceutical Firms' US Patenting Activities 37 16: Top Non-national firms patenting in Europe 38 17: Top Ten Biotechnology drugs on the Market in 1993 48 18: Alliances and Joint Ventures between US DBFs and leading European multinationals 50 19a: US-DBFs involved in biotechnology alliances 1982-91 '' .
    [Show full text]